KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silicon Laboratories (SLAB) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Silicon Laboratories (SLAB) over the last 17 years, with Q4 2025 value amounting to -$627000.0.

  • Silicon Laboratories' Cash from Financing Activities fell 24822.7% to -$627000.0 in Q4 2025 from the same period last year, while for Oct 2025 it was -$182000.0, marking a year-over-year increase of 9960.46%. This contributed to the annual value of -$45.1 million for FY2024, which is 9366.4% up from last year.
  • Per Silicon Laboratories' latest filing, its Cash from Financing Activities stood at -$627000.0 for Q4 2025, which was down 24822.7% from -$5.2 million recorded in Q3 2025.
  • Over the past 5 years, Silicon Laboratories' Cash from Financing Activities peaked at $6.6 million during Q4 2024, and registered a low of -$1.5 billion during Q1 2022.
  • Moreover, its 5-year median value for Cash from Financing Activities was -$45.7 million (2024), whereas its average is -$194.6 million.
  • Per our database at Business Quant, Silicon Laboratories' Cash from Financing Activities skyrocketed by 10286.79% in 2023 and then tumbled by 24822.7% in 2025.
  • Silicon Laboratories' Cash from Financing Activities (Quarter) stood at -$158.4 million in 2021, then dropped by 24.36% to -$197.0 million in 2022, then skyrocketed by 102.87% to $5.6 million in 2023, then rose by 16.45% to $6.6 million in 2024, then tumbled by 109.53% to -$627000.0 in 2025.
  • Its last three reported values are -$627000.0 in Q4 2025, -$5.2 million for Q3 2025, and -$958000.0 during Q2 2025.